Clinuvel Pharmaceuticals Ltd (CLVLY)
8.95
+0.01
(+0.11%)
USD |
OTCM |
Nov 13, 16:00
Clinuvel Pharmaceuticals Market Cap: 448.20M for Nov. 13, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 13, 2024 | 448.20M |
| November 12, 2024 | 447.70M |
| November 11, 2024 | 447.70M |
| November 08, 2024 | 447.55M |
| November 07, 2024 | 460.97M |
| November 06, 2024 | 449.47M |
| November 05, 2024 | 449.45M |
| November 04, 2024 | 459.46M |
| November 01, 2024 | 464.22M |
| October 31, 2024 | 477.29M |
| October 30, 2024 | 477.29M |
| October 29, 2024 | 468.23M |
| October 28, 2024 | 468.23M |
| October 25, 2024 | 466.47M |
| October 24, 2024 | 443.19M |
| October 23, 2024 | 469.23M |
| October 22, 2024 | 468.23M |
| October 21, 2024 | 468.23M |
| October 18, 2024 | 468.23M |
| October 17, 2024 | 473.24M |
| October 16, 2024 | 488.26M |
| October 15, 2024 | 488.26M |
| October 14, 2024 | 488.26M |
| October 11, 2024 | 475.74M |
| October 10, 2024 | 484.25M |
| Date | Value |
|---|---|
| October 09, 2024 | 468.23M |
| October 08, 2024 | 468.23M |
| October 07, 2024 | 509.79M |
| October 04, 2024 | 509.79M |
| October 03, 2024 | 486.51M |
| October 02, 2024 | 490.76M |
| October 01, 2024 | 490.76M |
| September 30, 2024 | 475.74M |
| September 27, 2024 | 475.74M |
| September 26, 2024 | 475.74M |
| September 25, 2024 | 500.78M |
| September 24, 2024 | 500.78M |
| September 23, 2024 | 500.78M |
| September 20, 2024 | 498.52M |
| September 19, 2024 | 498.52M |
| September 18, 2024 | 490.01M |
| September 17, 2024 | 506.79M |
| September 16, 2024 | 500.78M |
| September 13, 2024 | 500.78M |
| September 12, 2024 | 495.77M |
| September 11, 2024 | 493.27M |
| September 10, 2024 | 483.25M |
| September 09, 2024 | 488.26M |
| September 06, 2024 | 471.98M |
| September 05, 2024 | 471.98M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
400.22M
Minimum
Mar 18 2020
1.546B
Maximum
Sep 23 2021
739.47M
Average
685.20M
Median
Market Cap Benchmarks
| Alterity Therapeutics Ltd | 10.32M |
| Kazia Therapeutics Ltd | 18.97M |
| Immutep Ltd | 272.00M |
| Opthea Ltd | 575.54M |
| Mesoblast Ltd | 1.336B |
Market Cap Related Metrics
| PE Ratio | 19.52 |
| PS Ratio | 7.896 |
| PEG Ratio | 0.3339 |
| Price to Book Value | 3.303 |
| Price | 8.95 |
| Earnings Yield | 5.12% |
| PEGY Ratio | 0.3318 |
| Operating PE Ratio | 14.49 |
| Normalized PE Ratio | 19.52 |